Medication info

Rabeprazole Sodium 20 mg Tablets

Prescription medicationExpired
Ingredient · strength
Rabeprazole Sodium›Strength being verified
Manufacturer / importer
Jungheon Pharmaceutical Co., Ltd.
Appearance
Light yellow, round, enteric-coated tablet
Packaging
28 tablets (14 tablets x 2 PTP packs)
Approval status
Expired

MFDS item code 201801439 · Approved 2018.03.30

This product's status changed to Expired on 2023.03.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastroesophageal reflux disease, ulcers (including Helicobacter pylori eradication), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
Gastric and duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If healing has not occurred after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily dose is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms have resolved, subsequent symptoms may be controlled with on-demand treatment of 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution, as hepatic function is often reduced.
Children's dosage
Safety in children has not been established.

Ingredients

Manufacturer
Jungheon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, ulcers (including Helicobacter pylori eradication), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective for the treatment of ulcers in the stomach and duodenum. It also relieves symptoms of erosive or ulcerative gastroesophageal reflux disease and is used for long-term maintenance therapy. In patients with gastrointestinal ulcers caused by Helicobacter pylori infection, it enhances therapeutic effect when used in combination with antibiotics. Additionally, it is helpful for treating Zollinger-Ellison syndrome. In other words, it is widely used for the treatment and symptom improvement of various gastrointestinal diseases.

Dosage and Administration

Adult dosage

Gastric and duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If healing has not occurred after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily dose is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms have resolved, subsequent symptoms may be controlled with on-demand treatment of 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution, as hepatic function is often reduced.

Children's dosage

Safety in children has not been established.

Precautions

This medication should not be administered to patients allergic to specific components or benzimidazoles. Also, patients with allergies to certain antibiotics such as amoxicillin or clarithromycin during treatment to eradicate Helicobacter pylori should avoid using it. It should not be given to patients taking certain heart-related medications or drugs such as atazanavir, rilpivirine, pregnant or breastfeeding women. Caution should be exercised in administering to patients with impaired liver function, the elderly, and those with a history of drug allergies. During the use of this medication, hypersensitivity reactions such as skin rashes and itching may occur; if symptoms appear, the medication should be discontinued immediately. There may be various abnormalities such as decreased red or white blood cells and elevated liver enzymes noted in blood tests, so regular examinations are necessary. Adverse reactions in various body parts including the heart, digestive system, nervous system, respiratory system, musculoskeletal system, skin, eyes, and urinary system can occur; any unusual symptoms should be discussed with a physician. Long-term use may increase the risk of fractures due to osteoporosis, so caution is needed. This medication suppresses gastric acid secretion, which may increase the risk of bacterial infections in the gastrointestinal tract; if diarrhea or fever persists, visiting a hospital promptly is necessary. Caution should be taken as drowsiness or dizziness may occur while driving or operating machinery. This medication can interact with various drugs, so if other medications are being taken, it is essential to inform the healthcare provider. The safety of this medication has not been established for use during pregnancy or breastfeeding, so it is advisable not to use it. The safety for children has not been established, so it should not be administered to pediatric patients. This medication should be swallowed whole; it should not be chewed or crushed. When storing, keep it out of the reach of children, and do not transfer it to another container. There is no specific antidote for overdose; appropriate treatment should be given based on symptoms. Long-term use of this medication may result in impaired absorption of vitamin B12, so testing and supplementation may be necessary if needed. Autoimmune diseases may manifest as skin or systemic rashes resembling lupus erythematosus; if related symptoms occur, prompt medical attention is necessary. Use of this medication may affect the results of neuroendocrine tumor tests, so discontinuation before testing may be necessary.

Side effects

Rash, urticaria, itching, decreased red blood cells, decreased white blood cells, increased white blood cells, increased eosinophils, increased neutrophils, decreased lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, tachycardia, bradycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbances, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, muscle weakness, neural hyperexcitability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, limb flaccidity, sensory lethargy, decreased grip strength, language confusion, staggering, delirium, disorientation, somnolence, cough, pharyngitis, rhinitis, dyspnea, asthma, nosebleed, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonic muscle syndrome, neuralgia, isolated contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, kidney stones, uterine bleeding, polyuria, gynecomastia, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, lethargy, weight gain, visual disturbances, appetite loss, neck stiffness, photosensitivity reactions, hangover effects, weight loss, gout, anaphylactic reactions, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, angioedema, hypomagnesemia, thrombocytopenia, decreased neutrophils, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reactions, myalgia, arthralgia, interstitial nephritis, gynecomastia, increased thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, prolonged prothrombin time, bone fractures, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, discoid lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that can block light and moisture, at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow, round, enteric-coated tablet

Package unit

28 tablets (14 tablets x 2 PTP packs)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.